DAZZLE clinical trial : Kodiak Sciences doses first patients with KSI-301 in phase 3 wet AMD trial

pharmanewsdaily- October 15, 2019 0

Kodiak Sciences said that it has treated the first patients in the phase 2 DAZZLE clinical trial of KSI-301, its investigational intravitreal anti-VEGF antibody biopolymer ... Read More

FDA approves Dompé’s Oxervate for rare eye disease treatment

pharmanewsdaily- August 23, 2018 0

Dompé farmaceutici, an Italian pharmaceutical company, has achieved a milestone with the U.S. Food and Drug Administration (FDA) approval of Oxervate (cenegermin) eye drops for ... Read More